<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Aurobindo Pharma Limited

NSE: AUROPHARMA · Lot size: 550

OverviewOption ChainOI AnalysisFII / DIIMax Pain

Aurobindo Pharma Limited FII & DII Activity

FII Net (₹ Cr)
-1,059.93
Buy 12,756.88 · Sell 13,816.81
DII Net (₹ Cr)
+2,966.89
Buy 18,753.06 · Sell 15,786.17
FII F&O Net (contracts)
+0
Index + stock futures

5-Day Flow Trend

DateFII Net (₹ Cr)DII Net (₹ Cr)
2026-04-21-1,059.93+2,966.89
2026-04-20+683.2-4,721.48
2026-04-18+683.2-4,721.48
AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

Foreign Institutional Investors (FII) sold ₹1059.93 Cr in cash today, reflecting risk-off behavior amid global uncertainty. Domestic Institutional Investors (DII) countered with strong buying of ₹2966.89 Cr, signaling confidence in domestic fundamentals. FII-DII divergence remains elevated, with DIIs absorbing FII outflows.

Trend vs 5-Day Average

Today’s FII outflow breaks below their 5-day average of +₹683.2 Cr, indicating a sharp reversal in foreign sentiment. Conversely, DII inflow starkly contrasts their 5-day average of ₹-4721.48 Cr, marking a decisive shift in domestic buying momentum.

F&O Positioning Signal

FII participation in F&O stood at ₹0 Cr, showing no directional hedging or speculation in derivatives. The Index Futures long/short ratio at 1.2 suggests neutral-to-moderate bullish positioning at the broader market level, despite sectoral churn.

Implication for Finance

Persistent DII support amid FII pullback could bolster healthcare stocks like Aurobindo Pharma, lending stability to the sector tomorrow.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-04-21

Related Analysis

Same Sector

ABB
ABB India Limited
Neutral
ABCAPITAL
Aditya Birla Capital Limited
Neutral
ADANIENSOL
Adani Energy Solutions Limited
Neutral
ADANIENT
Adani Enterprises Limited
Neutral
ADANIGREEN
Adani Green Energy Limited
Neutral

Frequently Asked Questions

What is FII net buying/selling in Aurobindo Pharma Limited today?▾
FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹1,059.93 Cr (net selling) as of 2026-04-21. This market-wide figure applies to all F&O stocks including Aurobindo Pharma Limited.
What is DII activity in Aurobindo Pharma Limited today?▾
DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹2,966.89 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.
What is FII F&O net for Aurobindo Pharma Limited today?▾
FII net F&O position (index + stock futures combined) is +0 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.
Were there any block deals in Aurobindo Pharma Limited?▾
Block deal data for Aurobindo Pharma Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.
How does FII/DII data affect Aurobindo Pharma Limited stock price?▾
FII and DII flows are market-wide data — all F&O stocks including Aurobindo Pharma Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Aurobindo Pharma Limited's individual OI buildup type, this provides a directional framework.